Displaying 51 - 60 of 1348 Articles
Neurological Alliance Ireland (NAI)
22 Oct 2020

NAI Survey

Are you currently accessing any supports and services online for your Neurological condition? 

The National Transport Authority
08 Oct 2020

The National Transport Authority Survey

The National Transport Authority are interested in hearing the views and concerns of people across Ireland in relation to accessibility of public transport in their area. They have created a survey which they have asked us to share with you. 

MS Ireland Logo
MS Ireland
01 Oct 2020

OCREVUS (ocrelizumab) is now publicly available in Ireland

Ocrevus (ocrelizumab) is the first and only licensed treatment for people with early, inflammatory primary progressive multiple sclerosis in Ireland.

Dublin, 1st of October 2020 – Roche Products (Ireland) Ltd. (“Roche”), today, announced that OCREVUS® (ocrelizumab) is now publicly available in Ireland to treat people living with primary progressive multiple sclerosis (PPMS). More than 9,000 people in Ireland are living with MS(1) and it is estimated that PPMS, a highly disabling form of MS, and according to MS Ireland, affects approximately 15% of people diagnosed with MS(1).